English

Choose language

Back

  • Deutsch

  • ελληνική

  • English

  • Español

  • Français

  • Polski

  • Português

  • Русский

  • Українська


English

How do you prefer to top up your account?

* We don't charge any commission for making deposits into your account

Proto Labs Stock: 12% Profit Potential with High Demand

Company Name: Proto Labs, Inc.
Ticker: PRLB
Current Price: $121.25
Target Price: $136.00
Projected Yield: 11.90%
Time Line: 1 to 3 months
Risk: High

About Proto Labs, Inc.

Proto Labs, Inc. was founded in 1999 in the US, and is focusing on manufacturing custom prototype models and parts through 3D printing and high pressure casting. As of now, Proto Labs, Inc. is one of the fastest growing manufacturers in the industry, with presence in five countries.

What's the Idea?

Capitalize on a stock with a good profit potential with a high demand of company services.


Buy Proto Labs, Inc. Shares


Why Trade Proto Labs, Inc.?

Reason 1: High Demand

Proto Labs, Inc. is considered the fastest digital manufacturer of plastic and metal parts in the US. The company services are becoming more in-demand because of more protective gear (including masks and face shields) being produced.

Reason 2: Financial Data

Proto Labs has zero debt and only $7.9M in operating lease liabilities. Meanwhile, liquid assets, cash, and short term investments amount to $130.10M, which is enough to cover total liabilities 1.44 times, and current liabilities, 2.75 times. The gross margin is at 50.90%, with the average sales growth of 17% per year over the last five years.

Reason 3: Technical Analysis

The stock finally broke out after a long consolidation period. In case the diagonal channel resistance is broken out, the price may again reach the local high at $136.

Reason 4: Investment Bank Rating Upgrade

Benchmark has updated its recommendations to Buy and the target price, to $145, with an upside of around 20%.

How to Use the Investment Idea

1. Buy Proto Labs, Inc. shares at $121.25.

2. Allocate no more than 3% to 4% of your midterm transaction budget.

3. Sell the stock when the price is at $136 per share.

How to Buy Proto Labs, Inc. Shares?

There are two ways to do that:

Freedom24 Web Platform: Go to the Web Terminal section, type Proto Labs or PRLB (Proto Labs ticker in the NYSE) in the search bar, and select PRLB.US in the results. Open a secure session, in the trading window on the right, select the number of shares you want to buy, and click Buy.

Freedom24 iPhone App: Go to the Price screen and tab the search icon in the top right corner. In the dialog that shows up, type Proto Labs or PRLB (Proto Labs ticker in the NYSE) and select PRLB.US in the search results. You will then see Proto Labs stock in the market watch; tap it and go to the Order tab in the dialog that shows up. Specify the number of shares you want to buy and click Buy.

If you don't have an account yet, open it now : this can be done online, in just 10 minutes. All you need to do is fill out a short form and verify your account.

Invest into Proto Labs, Inc.: don't miss your chance where the stock is rising due to the high demand!

Buy Proto Labs, Inc. Shares


*Additional information is available upon request. Investment in securities and other financial instruments always involves risks of capital loss. The Client should make himself aware at his own accord, including to familiarize himself with Risk Disclosure Notice. Opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Commissions, fees or other charges can diminish financial returns. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and do not constitute an investment advice service. The recipient of this report must make their own independent decisions regarding any securities or financial instruments mentioned herein. Information has been obtained from sources believed to be reliable by Freedom Finance Cyprus Ltd or its affiliates and/or subsidiaries (collectively Freedom Finance). Freedom Finance do not warrant its completeness or accuracy except with respect to any disclosures relative to the Freedom Finance and/or its affiliates and the analyst’s involvement with the issuer that is the subject of the research. All pricing is indicative as of the close of market for the securities discussed, unless otherwise stated.